These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 28038867)

  • 1. Parkinsonian axial signs in schizophrenia.
    Morgante F; Barbui C; Tinazzi M;
    Parkinsonism Relat Disord; 2017 Mar; 36():89-92. PubMed ID: 28038867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study.
    Tinazzi M; Morgante F; Matinella A; Bovi T; Cannas A; Solla P; Marrosu F; Nicoletti A; Zappia M; Luca A; Di Stefano A; Morgante L; Pacchetti C; Minafra B; Sciarretta M; Dallocchio C; Rossi S; Ulivelli M; Ceravolo R; Frosini D; Cipriani A; Barbui C
    Schizophr Res; 2014 Feb; 152(2-3):344-9. PubMed ID: 24369987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease.
    Lorberboym M; Treves TA; Melamed E; Lampl Y; Hellmann M; Djaldetti R
    Mov Disord; 2006 Apr; 21(4):510-4. PubMed ID: 16250023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual parkinsonian motor signs and striatal dopamine transporter deficiency: a study with [I-123]FP-CIT SPECT.
    Mäkinen E; Joutsa J; Jaakkola E; Noponen T; Johansson J; Pitkonen M; Levo R; Mertsalmi T; Scheperjans F; Kaasinen V
    J Neurol; 2019 Apr; 266(4):826-834. PubMed ID: 30687897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.
    Tison F; Yekhlef F; Chrysostome V; Balestre E; Quinn NP; Poewe W; Wenning GK
    Mov Disord; 2002 Jul; 17(4):701-9. PubMed ID: 12210859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [123I]FP-CIT SPET imaging in drug-induced Parkinsonism.
    Tinazzi M; Ottaviani S; Isaias IU; Pasquin I; Steinmayr M; Vampini C; Pilleri M; Moretto G; Fiaschi A; Smania N; Giorgetti P; Antonini A
    Mov Disord; 2008 Oct; 23(13):1825-9. PubMed ID: 18759353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-CIT-SPECT combined with UPDRS appears to distinguish different parkinsonian conditions.
    Sjøholm H; Sundsfjord J; Mellgren SI
    Acta Neurol Scand; 2002 Jan; 105(1):5-7. PubMed ID: 11903101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower striatal dopamine transporter binding in neuroleptic-naive schizophrenic patients is not related to antipsychotic treatment but it suggests an illness trait.
    Mateos JJ; Lomeña F; Parellada E; Mireia F; Fernandez-Egea E; Pavia J; Prats A; Pons F; Bernardo M
    Psychopharmacology (Berl); 2007 Apr; 191(3):805-11. PubMed ID: 17019564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: a longitudinal beta-CIT SPECT study.
    Pirker W; Djamshidian S; Asenbaum S; Gerschlager W; Tribl G; Hoffmann M; Brücke T
    Mov Disord; 2002 Jan; 17(1):45-53. PubMed ID: 11835438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?
    Pirker W
    Mov Disord; 2003 Oct; 18 Suppl 7():S43-51. PubMed ID: 14531046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor structure of parkinsonian signs in the community-dwelling elderly.
    Louis ED; Tang MX; Mayeux R
    Mov Disord; 2004 Mar; 19(3):268-72. PubMed ID: 15022180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased striatal dopamine transporter binding assessed with [123I] FP-CIT in first-episode schizophrenic patients with and without short-term antipsychotic-induced parkinsonism.
    Mateos JJ; Lomeña F; Parellada E; Font M; Fernandez E; Pavia J; Prats A; Pons F; Bernardo M
    Psychopharmacology (Berl); 2005 Sep; 181(2):401-6. PubMed ID: 15830229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of 123I-ioflupane and 123I-iodobenzamide SPECT scans in 248 patients with parkinsonian syndromes.
    Vlaar AM; de Nijs T; Kessels AG; Vreeling FW; Winogrodzka A; Mess WH; Tromp SC; van Kroonenburgh MJ; Weber WE
    Eur Neurol; 2008; 59(5):258-66. PubMed ID: 18264015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quetiapine use in a patient with chronic schizophrenia and severe parkinsonism.
    Stoner SC; Lea JW; Wolf AL; Berges AA
    Pharmacotherapy; 2005 Nov; 25(11):1651-5. PubMed ID: 16232027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does levodopa slow or hasten the rate of progression of Parkinson's disease?
    Fahn S;
    J Neurol; 2005 Oct; 252 Suppl 4():IV37-IV42. PubMed ID: 16222436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study.
    Rossi C; Frosini D; Volterrani D; De Feo P; Unti E; Nicoletti V; Kiferle L; Bonuccelli U; Ceravolo R
    Eur J Neurol; 2010 Apr; 17(4):626-30. PubMed ID: 20050904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [(18)F] FP-CIT PET study in parkinsonian patients with leukoaraiosis.
    Lee MJ; Kim SL; Kim HI; Oh YJ; Lee SH; Kim HK; Han CS; Lyoo CH; Ryu YH; Lee MS
    Parkinsonism Relat Disord; 2015 Jul; 21(7):704-8. PubMed ID: 25937616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatal dopamine loss and discriminative sensory dysfunction in Parkinson's disease.
    Lyoo CH; Ryu YH; Lee MJ; Lee MS
    Acta Neurol Scand; 2012 Nov; 126(5):344-9. PubMed ID: 22380639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Prevalence of Early Parkinson's Disease in Patients With Subtle Parkinsonian Signs.
    Sasaki S
    Front Neurol; 2021; 12():656679. PubMed ID: 34305780
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report.
    Di Giuda D; Calcagni ML; Totaro M; Cocciolillo F; Piano C; Soleti F; Fasano A; Cioni B; Bentivoglio AR; Giordano A
    Nucl Med Commun; 2012 Sep; 33(9):933-40. PubMed ID: 22735298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.